Maqola

Revolutionizing Alzheimer's Disease Treatment: The Role of Novel Drug Delivery Systems and Artificial Intelligence

Tolepbergenova M.Rupanshi SahuPhD Scholar , Sagar Institute of Research Technology-Pharmacy , Sanjeev Agrawal Global EEeducation University , Bhopal , IndiaLidiya KhituovaDepartment of Pediatrics with a course of children's Infections diseases , Kazakh-Russian Medical University , Almaty , KazakhstanZholdasbay Altay DanaiulyIntervention cardiologist , AlmatyAbdugani MusayevDepartment of Emergency and First Aid , Asfendiyarov Kazakh National Medical University , Almaty , KazakhstanAlexandr LeonovDepartment of Molecular biology , general chemistry and biochemistry with the course of medical genetics Kazakh- Russian Medical University , Almaty , KazakhstanAbdukhalil MusaevDepartment of congenital and acquired ENT diseases , Republican Specialized Scientific and Practical Medical Center of Pediatrics , Tashkent , UzbekistanSanjay NagdevDept. of QA , Shri Prakashchand Jain College of Pharmacy & Research Jamner IndiaZhannat NurmakhanovaAssociate Professor, Dept. of General Medicine Asfendiyarov Kazakh National Medical University , Almaty , Kazakhstan

2025en

Ochiq kirishOltin

ABI

Annotatsiya

Alzheimer's disease is a multifaceted neurodegenerative disorder with no definitive cure, posing significant challenges in treatment. Recent advancements in drug delivery systems, particularly through nanotechnology, and the integration of artificial intelligence and machine learning, have offered promising new avenues for enhancing AD management. Nanoparticle-based drug delivery systems are being utilized to improve the targeting and bioavailability of therapeutic agents, allowing more efficient crossing of the blood-brain barrier. Concurrently, AI-driven approaches are being employed to facilitate early diagnosis, optimize treatment strategies, and predict patient outcomes by analyzing complex datasets, including brain imaging and biomarker data. Also, a multidrug, multi-target treatment approach, similar to chemotherapy, is emerging as a potential strategy for addressing the complexity of AD. This review discusses the various AI and nanotechnology-driven innovations in AD, the current challenges in treatment, and the future directions for research. Continued exploration of these technologies, combined with early detection, lifestyle interventions, and precision medicine, holds the potential to revolutionize AD care, minimizing disease recurrence and enhancing patient quality of life.

Hali tarjima qilinmagan

Identifikatorlar

DOI: 10.64149/j.carcinog.24.7s.414-431

Iqtiboslar va manbalar

0 ta iqtibos0 ta foydalanilgan manba